Pharma investment freeze in Germany deepens as Boehringer and Eli Lilly scale back projects German pharmaceutical investment freeze alarms industry as lawmakers approve higher manufacturer rebates and tougher pricing rules …
Pharma
-
Business
Pharma industry warns coalition health bill will cost sector 19.2 billion euros
by Leo Müllerby Leo MüllerGerman pharmaceutical industry warns of €4.6bn extra burden from healthcare savings law German pharmaceutical industry warns new healthcare savings law will impose €4.6bn extra on drugmakers via higher rebates and …
-
Business
German pharma faces US Section 301 probe over drug pricing and reforms
by Leo Müllerby Leo MüllerU.S. launches Section 301 probe into German drug pricing, raising tariff threat to pharma U.S. opens Section 301 probe into German drug pricing, examining whether Germany underpays innovative medicines; tariffs …
-
Business
Helium shortage threatens German pharma and medical supply after Gulf attacks
by Leo Müllerby Leo MüllerHelium Shortage Deepens as Qatar Facility Attacks Disrupt Global Supply Global helium shortage escalates after attacks on QatarEnergy sites cut exports by roughly 30–40%, driving price spikes and threatening hospitals, …
-
Business
Pharma Industry Warns German Reform Raising Manufacturer Rebates Will Curb Investment
by Leo Müllerby Leo MüllerGerman health insurance reform draws sharp pharma backlash over dynamic manufacturer discount German health insurance reform sparks pharma alarm as manufacturers warn that dynamic hikes to the manufacturer discount threaten …